Vitamin D receptor polymorphisms and expression profile in rheumatoid arthritis brazilian patients

Molecular Biology Reports

Volumn 43, Issue 1, 2016, Pages 41-51

  Cavalcanti, Catarina Addobbati Jordão ^a   de Azevêdo Silva, Jaqueline ^a   de Barros Pita, Will ^a   Veit, Tiago Degani ^b   Monticielo, Odirlei Andre ^c   Xavier, Ricardo Machado ^c   Brenol, João Carlos Tavares ^c   Brenol, Cleiton Viegas ^c   Fragoso, Thiago Sotero ^d   Barbosa, Alexandre Domingues ^a   Duarte, Ângela Luiza Branco Pinto ^a   Oliveira, Renê Donizeti Ribeiro ^e   Louzada Júnior, Paulo ^e   Donadi, Eduardo Antônio ^e   Crovella, Sergio ^a   Chies, José Artur Bogo ^b   Sandrin Garcia, Paula ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Monocytes; mRNA; Rheumatoid arthritis; SNPs; VDR

Indexed keywords

MESSENGER RNA; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; VDR PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD LEVEL; BRAZILIAN; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MONOCYTE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN D RECEPTOR GENE; ALLELE; BLOOD; BRAZIL; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS;

ALLELES; ARTHRITIS, RHEUMATOID; BRAZIL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL;

EID: 84954362327     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-015-3937-z     Document Type: Article

References (57)

1. Hitchon CA, El-Gabalawy HS (2011) The synovium in rheumatoid arthritis. Open Rheumatol J 5:107–114
2. Tobón GJ, Youinou P, Saraux A (2010) The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 9:288–292
3. Alamanos Y, Drosos AA (2005) Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 4:130–136
4. Jacob N, Jacob CO (2012) Genetics of rheumatoid arthritis: an impressionist perspective. Rheum Dis Clin N Am 38:243–257
5. Lemire JM, Archer DC, Beck L, Spiegelberg HL (1995) Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 125:1704S–1708S
6. Penna G, Amuchastegui S, Cossetti C, Aquilano F, Mariani R, Sanvito F et al (2006) Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol. J Immunol 177:8504–8511
7. Tang J, Zhou R, Luger D, Zhu W, Silver PB, Grajewski RS et al (2009) Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 182:4624–4632
8. Joshi S, Pantalena LC, Liu XK, Gaffen SL, Liu H, Rohowsky-Kochan C et al (2011) 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol 31:3653–3669
9. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A (2001) 1α,25-Dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167:4974–4980
10. Rudensky AY (2011) Regulatory T cells and Foxp3. Immunol Rev 241:260–268
11. Ardalan MR, Maljaei H, Shoja MM, Piri AR, Khosroshahi HT, Noshad H et al (2007) Calcitriol started in the donor, expands the population of CD4+ CD25+ T cells in renal transplant recipients. Transpl Proc 39:951–953
12. Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179:1634–1647
13. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG, Iowa Women’s Health Study (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 50:72–77
14. Song GG, Bae SC, Lee YH (2012) Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin Rheumatol 31:1733–1739
15. Oelzner P, Müller A, Deschner F, Hüller M, Abendroth K, Hein G et al (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62:193–198
16. Rossini M, Maddali Bongi S, La Montagna G, Minisola G, Malavolta N, Bernini L et al (2010) Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther 12:R216
17. Xiong J, He Z, Zeng X, Zhang Y, Hu Z (2014) Association of vitamin D receptor gene polymorphisms with systemic lupus erythematosus: a meta-analysis. Clin Exp Rheumatol 32:174–181
18. Monticielo OA, Brenol JC, Chies JA, Longo MG, Rucatti GG, Scalco R et al (2012) The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus 21:43–52
19. García-Martín E, Agúndez JA, Martínez C, Benito-León J, Millán-Pascual J, Calleja P et al (2013) Vitamin D3 receptor (VDR) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis. PLoS One 8:e65487
20. Huang J, Xie ZF (2012) Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: a meta-analysis of case-control studies. J Neurol Sci 313:79–85
21. Tizaoui K, Kaabachi W, Hamzaoui A, Hamzaoui K (2014) Contribution of VDR polymorphisms to type 1 diabetes susceptibility: systematic review of case-control studies and meta-analysis. J Steroid Biochem Mol Biol 143C:240–249
22. De Azevêdo Silva J, Guimarães RL, Brandão LA, Araujo J, Segat L, Crovella S et al (2013) Vitamin D receptor (VDR) gene polymorphisms and age onset in type 1 diabetes mellitus. Autoimmunity 46:382–387
23. Zhou H, Xu C, Gu M (2009) Vitamin D receptor (VDR) gene polymorphisms and Graves’ disease: a meta-analysis. Clin Endocrinol (Oxf) 70:938–945
24. Tizaoui K, Kaabachi W, Ouled Salah M, Ben Amor A, Hamzaoui A, Hamzaoui K (2014) Vitamin D receptor TaqI and ApaI polymorphisms: a comparative study in patients with behcet’s disease and rheumatoid arthritis in Tunisian population. Cell Immunol 290:66–71
25. Mosaad YM, Hammad EM, Fawzy Z, Abdal Aal IA, Youssef HM, ElSaid TO et al (2014) Vitamin D receptor gene polymorphism as possible risk factor in rheumatoid arthritis and rheumatoid related osteoporosis. Hum Immunol 75:452–461
26. Hussien YM, Shehata A, Karam RA, Alzahrani SS, Magdy H, El-Shafey AM (2013) Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. Mol Biol Rep 40:3675–3680
27. Karray EF, Dhifallah IB, Abdelghani KB, Ghorbel IB, Khanfir M, Houman H et al (2012) Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behçet’s disease in Tunisians. Joint Bone Spine 79:144–148
28. Hitchon CA, Sun Y, Robinson DB, Peschken CA, Bernstein CN, Siminovitch KA et al (2012) Vitamin D receptor polymorphism rs2228570 (Fok1) is associated with rheumatoid arthritis in North American natives. J Rheumatol 39(9):1792–1797
29. Maalej A, Petit-Teixeira E, Michou L, Rebai A, Cornelis F, Ayadi H (2005) Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immun 6:707–711
30. Goertz B, Fassbender WJ, Williams JC, Marzeion AM, Bretzel RG, Stracke H et al (2003) Vitamin D receptor genotypes are not associated with rheumatoid arthritis or biochemical parameters of bone turnover in German RA patients. Clin Exp Rheumatol 21:333–339
31. Lee CK, Hong JS, Cho YS, Yoo B, Kim GS, Moon HB (2001) Lack of relationship between vitamin D receptor polymorphism and bone erosion in rheumatoid arthritis. J Korean Med Sci 16:188–192
32. Garcia-Lozano JR, Gonzalez-Escribano MF, Valenzuela A, Garcia A, Núñez-Roldán A (2001) Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur J Immunogenet 28:89–93
33. Kinne RW, Stuhlmüller B, Burmester GR (2007) Cells of the synovium in rheumatoid arthritis. Macrophages. Arthritis Res Ther 9:224
34. Kay J, Upchurch KS (2012) ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatol (Oxf) 51(Suppl 6):vi5-9
35. Lahiri DK, Nurnberger JI (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444
36. Cox DG, Canzian F (2001) Genotype transposer: automated genotype manipulation for linkage disequilibrium analysis. Bioinformatics 17:738–739
37. Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48
38. Van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850
39. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta DeltaC(T)) Method. Methods 25:402–408
40. Boissier MC, Semerano L, Challal S, Saidenberg-Kermanac’h N, Falgarone G (2012) Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction. J Autoimmun 39:222–228
41. Kerr GS, Sabahi I, Richards JS, Caplan L, Cannon GW, Reimold A et al (2011) Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J Rheumatol 38:53–59
42. Gopinath K, Danda D (2011) Supplementation of 1,25dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial. Int J Rheum Dis. 14:332–339
43. Furuya T, Hosoi T, Tanaka E, Nakajima A, Taniguchi A, Momohara S et al (2013) Prevalence of and factors associated with vitamin D deficiency in 4793 Japanese patients with rheumatoid arthritis. Clin Rheumatol 32:1081–1087
44. Haga HJ, Schmedes A, Naderi Y, Moreno AM, Peen E (2013) Severe deficiency of 25-hydroxyvitamin D(3) (25-OH-D (3)) is associated with high disease activity of rheumatoid arthritis. Clin Rheumatol 32:629–633
45. Pike JW, Meyer MB, Watanuki M, Kim S, Zella LA, Fretz JA et al (2007) Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor. J Steroid Biochem Mol Biol 103:389–395
46. Haussler MR, Haussler CA, Bartik L, Whitfield GK, Hsieh JC, Slater S et al (2008) Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 66:S98–S112
47. Brennan A, Katz DR, Nunn JD, Barker S, Hewison M, Fraher LJ et al (1987) Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 61:457–461
48. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (1983) 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221:1181–1183
49. Tetlow LC, Smith SJ, Mawer EB, DE Woolley (1999) Vitamin D receptors in the rheumatoid lesion: expression by chondrocytes, macrophages, and synoviocytes. Ann Rheum Dis1 58:118–121
50. Cantorna MT, Hayes CE, DeLuca HF (1998) 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 128:68–72
51. Laragione T, Shah A, Gulko PS (2012) The vitamin D receptor regulates rheumatoid arthritis synovial fibroblast invasion and morphology. Mol Med 18:194–200
52. de Azevêdo Silva J, Monteiro Fernandes K, Trés Pancotto JA, Sotero Fragoso T, Donadi EA et al (2013) Vitamin D receptor (VDR) gene polymorphisms and susceptibility to systemic lupus erythematosus clinical manifestations. Lupus 22:1110–1117
53. Holwerda SJ, de Laat W (2013) CTCF: the protein, the binding partners, the binding sites and their chromatin loops. Philos Trans R Soc Lond B Biol Sci 368:20120369
54. Zwerina K, Baum W, Axmann R, Heiland GR, Distler JH, Smolen J et al (2011) Vitamin D receptor regulates TNF-mediated arthritis. Ann Rheum Dis 70:1122–1129
55. Sun J, Kong J, Duan Y, Szeto FL, Liao A, Madara JL et al (2006) Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 291:E315–E322
56. Moelants EA, Mortier A, Van Damme J, Proost P (2013) Regulation of TNF-α with a focus on rheumatoid arthritis. Immunol Cell Biol 91:393–401
57. Okamoto H, Cujec TP, Yamanaka H, Kamatani N (2008) Molecular aspects of rheumatoid arthritis: role of transcription factors. FEBS J 275:4463–4470